# US 9,517,073 B1 · Inflatable balloon stent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 9,517,073 B1
- Document ID: US9517073B1
- Status: Granted
- Kind: B1
- Application number: 14/876,531
- Filed: 2015-10-06
- Granted: 2016-12-13
- Earliest claimed: 2011-10-21
- Applicants: Michael Christopher Morris
- Inventors: Michael Christopher Morris
- Web page: https://patentgrep.com/patent/US9517073B1

## CPC

- A61B 17/12136: {Balloons}
- A61B 17/12036: {partial occlusion}
- A61B 17/12045: {double occlusion, e.g. during anastomosis}
- A61B 17/12099: {characterised by the location of the occluder}
- A61F 2/04: Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95)
- A61M 1/00: Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems (catheters A61M25/00; tube connectors, tube couplings, valves or branch units specially adapted for medical use A61M39/00; devices for taking samples of blood A61B5/15; filters implantable into blood vessels A61F2/01)
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61B 2017/00566: {fixation of form upon application of vacuum}
- A61B 2017/00818: {Treatment of the gastro-intestinal system}
- A61B 2217/005: with suction drainage system
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61F 2002/045: {Stomach, intestines}
- A61F 2210/0061: swellable
- A61F 2250/0003: having an inflatable pocket filled with fluid, e.g. liquid or gas
- A61M 1/916: {specially adapted for deep wounds}
- A61M 25/1011: {Multiple balloon catheters}
- A61M 29/02: Dilators made of swellable material {(balloon catheters for angioplasty A61M25/104)}
- A61M 2025/1061: {having separate inflations tubes, e.g. coaxial tubes or tubes otherwise arranged apart from the catheter tube}
- A61M 2025/1086: {having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves}
- A61M 2025/1097: {with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon}
- A61M 2210/106: Small intestine
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method for confined and controlled treatment of a target area of an internal body lumen using negative pressure applied to the target area, the method permitting treatment to proceed without interrupting the flow of bodily fluid through the body lumen, the method including deploying a resilient stent having a liner to define the target area and passages within the liner connected to a catheter tube so that the negative pressure may be applied through a lumen of the catheter tube from a source connected to the catheter tube without impacting the inflated stent and without impacting the ability of body lumen fluid to flow through the stent, thereby permitting therapy to proceed without disrupting the natural flow of bodily fluids or the delivery of nutrients within the body lumen during therapy.

## Claims

### Claim 1

A method for confined and controlled treatment of a target area [TA] of an internal body lumen using negative pressure applied to the target area[TA], the method permitting treatment to proceed without interrupting the flow of bodily fluid through the body lumen, the method comprising:
deploying within the body lumen of a patient a resilient stent [12] having a generally elongate shape with a longitudinal axis from a proximal end to a distal end, the resilient stent having an external surface [12a], and an internal surface [12b],
defining a target area [TA] within the body lumen by inflating a proximal portion [18a], a distal portion [18b], and an intermediate portion [18c] of the stent, where the proximal, distal and intermediate portions define a single plenum [18d], the intermediate portion comprising a plurality of passages [30] extending from the external surface [12a] to the internal surface [12b] to permit the passage of fluid from the target area fluid [TA] through the passages separated in a sealed manner from any air in the plenum [18d] so that when the single plenum defined by the proximal, distal, and intermediate portions is inflated, the target area fluid may still flow through the passages [30] without impacting the inflated plenum, the stent being deployed such that the passages permit an area adjacent the external surface of the stent to be in fluid communication with an area adjacent the internal surface of the stent through the passages, where an area [44c] is defined by the internal surface [12b] of the stent and an external surface [36a] of a wall of a perforated resilient liner [36] configured to be secured to the internal surface [12b] of the stent at a proximal end [44a] and distal end [44b] of the liner, the liner [36] defining the wall having the external surface [36a] , an internal surface [36b] , and a plurality of liner holes [39] therethrough between proximal and distal ends of the liner, the liner holes arranged generally linearly between the proximal [44a] and distal [44b] ends of the liner [36], the liner configured such that when the liner is secured to the stent [12] the external surface [36a] of the liner is adjacent the internal surface [12b] of the stent [frame] but separated therefrom, the internal surface [36b] of the liner defining an internal stent area [38] through which body lumen fluid may flow longitudinally within the generally elongate stent separate from any fluid flowing between the passages and separate from any air within the plenum, whereby the target area [TA] is defined generally by the proximal and distal portions of the stent at proximal and distal ends of the target area [TA], respectively, and by the body lumen wall and the external surface of the stent along the sides of the target area [TA], and
creating a negative pressure environment in the target area [TA] of the body lumen by securing in a sealable manner to the liner holes [39] a catheter tube [10] along the internal surface of the liner, where the a catheter tube [10] comprises a lumen [24] and having a proximal end, a distal end, and a plurality of catheter tube holes [32] positioned between the proximal and distal ends of the catheter tube, the catheter tube holes configured to be secured so that the lumen of the catheter tube may be in fluid communication with the stent passages where the negative pressure may be applied to the lumen of the catheter tube from a source connected to the proximal end of the catheter tube without impacting the inflated plenum and without impacting the ability of body lumen fluid to flow through the internal area of the stent, thereby permitting therapy to proceed without disrupting the natural flow of bodily fluids or the delivery of nutrients within the body lumen during therapy.

### Claim 2 (depends on 1)

The method of claim 1, wherein passages of the intermediate portion of the stent are arranged in a circumferential array radially positioned about the stent permitting a substantially even distribution of negative pressure to the target area.

### Claim 3 (depends on 1)

The method of claim 1, further comprising directing nutrient fluids into the body lumen during treatment through a second lumen [22] in the catheter tube [10] .